Body Mass Index and Outcomes in HR+/HER2− Metastatic Breast Cancer Treated with Palbociclib: Insights from a National Real-World Study.
Saved in:
| Title: | Body Mass Index and Outcomes in HR+/HER2− Metastatic Breast Cancer Treated with Palbociclib: Insights from a National Real-World Study. |
|---|---|
| Authors: | Badau, Larisa Maria1,2,3 (AUTHOR), Epure, Paul2,4 (AUTHOR), Margan, Madalin-Marius3,5 (AUTHOR) margan.madalin@umft.ro, Margan, Roxana3,4,6 (AUTHOR), Ciocoiu, Andrei Dorin1,5,7 (AUTHOR), Oprean, Cristina Marinela2,6,8 (AUTHOR), Vlaicu, Brigitha3,7 (AUTHOR) |
| Source: | Cancers. May2026, Vol. 18 Issue 9, p1379. 21p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 20726694 |
|---|---|
| DOI: | 10.3390/cancers18091379 |
